Back to search

National and Kapodistrian University of Athens

Έλεγχος της οστικής πυκνότητας σε παιδιά υπό μακροχρόνια λήψη βαρφαρίνης ή ασενοκουμαρόλης

Abstract

dc:description

Oral anticoagulants antagonize vtamin K action and potentially impair the carboxylation of osteocalcin, a protein essential for normal bone matrix formation. In the present study, bone mineral density and bone turnover markers were evaluated in 23 children (median age:11 years) under long-term oral anticoagulant therapy (median duration:4 years). Bone mineral density (BMD) of the lumbar spine was assessed (Dual Energy X-ray Absorptiometry) and reported as z-score. Osteoblast [bone alkaline phosphatase (BAP), osteocalcin (Gla-Oc), amino-terminal procollagen 1 extension peptide (PINP)] and osteoclast [urinary calcium and deoxypyridinoline (DPD), serum cross-linked C telopeptide (ICTP)] activity markers were measured. Vitamin D [(25[OH]D), parathormone (PTH), calcium, phosphorus, magnesium] and vitamin K status [factors II, VII, IX, X, protein C, protein S, undercarboxylated osteocalcin (Glu-Oc)] were determined. All the above biochemical and hemostatic parameters were also evaluated in 25 healthy controls. Twelve patients (52%) showed signs of osteopenia (-1> BMD z-score >-2.5), while the rest of them had normal bone density (BMD z-score >-1). Patients presented with lower levels in coagulation factors and natural inhibitors of hemostasis in comparison to controls, as was expected (II: median:38%, p:<0.001,VII: median:22%, p:<0.001, IX: median:40%, p:<0.001, X: median:17%, p:<0.001, protein C: median:50%, p:<0.001, protein S: median:55%, p=0.001). PTH and Glu-OC, which reflects hypovitaminosis K, levels were increased in patients in comparison to controls (median: 32.5, p=0.005 and median:11.75, p<0.001 respectively). In contrast, patients presented with lower levels of 25(OH)D (median:27 p=0.005). Levels of osteoblast activity markers were lower (Gla-Oc: median:5.6, p<0.001, BAP: median:54.5, p=0.017, PINP: median:462.4, p<0.001), while levels of osteoclast activity markers were higher (ICTP: median:18, p<0.001, DTP/Cr : median:21.6, p<0.001) in patients in comparison to controls. Statistical analysis demonstrated that anticoagulant therapy was an independent predictor of alterations in Glu-OC, Gla-Oc, BAP, PINP and ICTP levels in patients. It seems that long-term use of coumarin derivatives may cause osteopenia in children with the risk of developing osteoporosis later in life. This side-effect is probably due to impaired vitamin K status, taking into consideration that the relatively low levels of 25(OH)D in patients were proved to be a confounding factor in statistical analysis.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Avgeri, Maria
  • Αυγέρη, Μαρία

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/25423

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Avgeri, Maria; Αυγέρη, Μαρία. Έλεγχος της οστικής πυκνότητας σε παιδιά υπό μακροχρόνια λήψη βαρφαρίνης ή ασενοκουμαρόλης. National and Kapodistrian University of Athens, 2009. http://hdl.handle.net/10442/hedi/25423